Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

811-820 of 1245 results

Catalogue Number:

RHB93901

Category:

Anti-Human NPY Antibody (SAA0521)

Targets:	Pro-neuropeptide Y, CPON, NPY, Neuropeptide tyrosine
Species Reactivity:	Human, Mouse, Rat
Application:	Immunohistochemistry
Type:	Primary Recombinant
Isotypes/Mimetics:	IgG2a, kappa
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHB93902

Category:

Anti-Human NPY/Neuropeptide Y Antibody (L115/13)

Targets:	NPY, Pro-neuropeptide Y
Species Reactivity:	Human
Application:	Immunohistochemistry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHF92901

Category:

Anti-Human NRG1/Neuregulin-1 Antibody (SAA0828)

Targets:	Glial growth factor, Neu differentiation factor, SMDF, Breast cancer cell differentiation factor p45, Pro-neuregulin-1, membrane-bound isoform, Acetylcholine receptor-inducing activity, ARIA, GGF, HRGA, Pro-NRG1, HGL, HRG, NDF, NRG1, Sensory and motor neuron-derived factor, Heregulin
Species Reactivity:	Human
Applications:	Immunohistochemistry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHA91401

Category:

Anti-Human NRP2 Antibody (SAA1517)

Targets:	Vascular endothelial cell growth factor 165 receptor 2, Neuropilin-2, VEGF165R2, NRP2
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotypes/Mimetics:	IgG2a, kappa
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHK22001

Category:

Anti-Human NSD3/WHSC1L1 IP Antibody (SAA0250)

Targets:	Wolf-Hirschhorn syndrome candidate 1-like protein 1, NSD3, WHSC1-like 1 isoform 9 with methyltransferase activity to lysine, Nuclear SET domain-containing protein 3, WHSC1-like protein 1, WHSC1L1, Protein whistle, Histone-lysine N-methyltransferase NSD3
Species Reactivity:	Human
Applications:	ELISA, Immunofluorescence, Immunoprecipitation
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHC03101

Category:

Anti-Human Osteocalcin/BGP/OC Antibody (KTM219)

Targets:	Gamma-carboxyglutamic acid-containing protein, BGLAP, BGP, Bone Gla protein, Osteocalcin
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotypes/Mimetics:	IgG2a, kappa
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHK09902

Category:

Anti-Human oxLDL Antibody (SAA0552)

Targets:	oxidised LDL, oxidised form of low-density lipoprotein (LDL), oxidised low-density lipoproteins, oxidized low-density lipoprotein, oxidized low-density lipoproteins, OxLDL
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry, Immunohistochemistry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHK09903

Category:

Anti-Human oxLDL Antibody (SAA0553)

Targets:	oxidised LDL, oxidised form of low-density lipoprotein (LDL), oxidised low-density lipoproteins, oxidized low-density lipoprotein, oxidized low-density lipoproteins, OxLDL
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHK09904

Category:

Anti-Human oxLDL Antibody (SAA0554)

Targets:	oxidised LDL, oxidised form of low-density lipoprotein (LDL), oxidised low-density lipoproteins, oxidized low-density lipoprotein, oxidized low-density lipoproteins, OxLDL
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RHM02504

Category:

Anti-Human p53 (R175H mutation) pHLA Complex Antibody (H2)

Targets:	TP53, Cellular tumor antigen p53, Tumor suppressor p53, HLA-A, HLA class I histocompatibility antigen, A-2 alpha chain, MHC class I antigen A2, HLA-A02:01
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry, Other
Other Application:	SPR
Type:	Primary Recombinant
Isotypes/Mimetics:	IgG2a, kappa
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Viewing 811-820 of 1245 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.